Ukuvimbela uhlobo lwesifo sikashukela sohlobo 1, amangqamuzana amanyikwe abhekene nokukhiqiza i-insulin kubantu abasengozini enkulu yesifo kufanele avinjelwe ekubhujisweni. Ngokusho kweCanada Diabetes Association, ayikho ayikho indlela ephumelelayo nephephile okwamanje ukuvikela lesi sifo, noma ngabe sibonisana kusenesikhathi empilweni yengane ebhekwa njengengozi. Ngakho-ke, noma yiziphi izinyathelo zokuvimbela uhlobo lwesifo sikashukela sohlobo 1 kufanele zenziwe ngokubambisana nodokotela futhi kwezinye izimo, njengengxenye yocwaningo lokuhlola.⁴.

Ucwaningo oluqhubekayo

• Vitamin D. Ucwaningo oluningiliziwe lubonise ukuthi ukwengezelwa kukavithamini D wezingane ezisencane kwehlise kakhulu amathuba okuba nesifo sikashukela sohlobo 1 (imithamo yansuku zonke isukela ku-400 IU kuye ku-2 IU)¹³. Kodwa-ke, asikho isilingo somtholampilo esingakafiki ukuqinisekisa lokhu.¹¹. Ngenxa yokungabikho kwezingozi ezihambisana nokuthatha i-vitamin D kanye nezinzuzo zayo eziningi zezempilo, abanye odokotela bayayincoma njengendlela yokuvimbela;
• immunotherapy. Le yindlela ethembisa kakhulu, futhi leyo ososayensi abatshala izimali kakhulu kuyo. I-Immunotherapy ihlose ukuvumela amasosha omzimba ukuthi "abekezelele" amaseli ku-pancreas abhekele ukukhiqiza i-insulin. Izinhlobo eziningi ze-immunotherapy ziyahlolwa, ngokwesibonelo⁵ umuthi wokugoma owakhiwe ngama-antigen avela kumanyikwe womuntu ozolashwa; ukufakelwa kwe-autologous kwamaseli omzimba ukususa amaseli abhubhisayo futhi avumele ukwakhiwa kwamaseli amasha abekezelayo; kanye nokumpontshelwa igazi elithathwe enkabeni ngesikhathi sokuzalwa (ezinganeni ezincane);
• Uvithamini B3. Izinsuku kwesibeletho kanye nokuhlolwa kwezilwane kusekele umbono wokuthi i-niacinamide (uvithamini B3) ingaba nomthelela wokuvikela kumaseli we-beta epancreatic. Izivivinyo ezimbalwa zokuqala zokwelashwa nazo zilikhulisile leli themba⁶. Kodwa-ke, izifundo ezinkulu azange ziveze imiphumela ekholisayo. Isibonelo, njengengxenye ye-European Nicotinamide Diabetes Intervention Trial (ENDIT)⁷, imithamo ephezulu ye-niacinamide noma i-placebo yanikezwa abantu abangama-552 abasengozini yesifo sikashukela sohlobo 1 (isihlobo esiseduze esithintekile, ukuba khona kwama-autoantibodies ngokumelene namanyikwe nokuhlolwa okujwayelekile kokubekezelelana kwe-glucose). INiacinamide ayinciphisanga ubungozi bokuhlaselwa yisifo sikashukela.
• Ukujova imithamo ephansi ye-insulin. Enye yezindlela zokuvimbela ezivivinyiwe ukunikela ngemithamo emincane ye-insulin kubantu abasengozini. Le ndlela ihlolwe njengengxenye Yesivivinyo Sokuvikela Isifo Sikashukela - Uhlobo 1^8,9. Ukwelashwa kwe-insulin kwakungekho mphumela wokuvimbela ngaphandle kweqembu elincane elinobungozi, lapho ukuqala kwesifo sikashukela kwabambezeleka khona kancane.

Enye yezinselelo ocwaningweni ukukhomba abantu abasengozini enkulu yokuthola lesi sifo. Ukuvela egazini lama-antibodies ngokumelene namaseli we-beta amanyikwe (ama-autoantibodies) kungenye yezinkomba ezifundwe. La ma-antibody angaba khona iminyaka ngaphambi kokuqala kwalesi sifo. Njengoba kunezinhlobo eziningana zala ma-antibody, kungumbuzo wokuthola ukuthi iziphi ezibikezela kakhulu kulesi sifo, nokuthi sisuka kubuphi ubuningi¹⁰.

Bheka inkinga yethu yesifo sikashukela.